Orum Taking Novel ADC Approach To Protein Degradation
New Funding To Advance Lead Candidates
Orum Therapeutics executives talk to Scrip on the next steps for the targeted protein degradation pioneer after a large-scale financing and on likely developments in the space in the coming years.
